Quality of life improvement at midterm follow-up after transcatheter aortic valve implantation

Gonçalves, Alexandra; Marcos‐Alberca, Pedro; Almerı́a, Carlos; Feltes, Gisela; Hernández-Antolín, Rosa Ana; Rodrı́guez, Enrique; Rodrigo, José Luis; Cobiella, Javier; Maroto, Luis; Silva-Cardoso, José; Macaya, Carlos; Zamorano, José Luís

doi:10.1016/j.ijcard.2011.05.050

Cited by 36 publications

(27 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This clinical description shows how aortic systolic regurgitation may disappear in a patient as contractile intrinsic myocardial performance (assessed with tissue-Doppler derived myocardial strain) improves, despite little change in LVEF but with improved self referred quality of life as pointed out by Gonçalves A et al in patients after TAVI [2]. Heart rate, blood pressure and morphology and coupling interval of ventricular premature complexes were similar immediately after TAVI and in follow-up in this case.…”

supporting

confidence: 65%

“…Transcatheter aortic valve implantation (TAVI) is changing the way valvular aortic stenosis is managed in high risk patients, allowing to increase the total number of treated patients, reducing global mortality [1] and improving quality of life at midterm [2]. As ventricular systole is sometimes unable to overcome aortic arterial pressure, aortic regurgitation during the whole systole may occur.…”

mentioning

confidence: 99%

See 1 more Smart Citation

A simple echo-Doppler sign to assess improved myocardial performance after transcatheter aortic valve implantation

Saura¹,

Oliva-Sandoval

González-Carrillo

et al. 2012

International Journal of Cardiology

View full text Add to dashboard Cite

supporting

confidence: 65%

mentioning

confidence: 99%

A simple echo-Doppler sign to assess improved myocardial performance after transcatheter aortic valve implantation

Saura¹,

Oliva-Sandoval

González-Carrillo

et al. 2012

International Journal of Cardiology

View full text Add to dashboard Cite

“…Studies showed a clinically important improvement in the following disease-specific or physical functional measures: Kansas City Cardiomyopathy Questionnaire(8, 9, 72), Minnesota Living with Heart Failure Questionnaire(33, 68, 73), 6-minute walk test(31, 33, 38, 55, 57), and ADL limitations(58). The results were less consistent in general health measure: EuroQol-5D(9, 69, 72) (See Appendix Table 4).…”

Section: Resultsmentioning

confidence: 99%

Functional Status and Quality of Life After Transcatheter Aortic Valve Replacement

et al. 2014

View full text Add to dashboard Cite

Background Transcatheter aortic valve replacement (TAVR) prolongs survival in high-risk patients with severe aortic stenosis. However, its functional and quality-of-life benefits have not been established. Purpose To evaluate the changes in functional status and quality of life after TAVR. Data Sources MEDLINE, Embase, and Cochrane Central Register of Controlled Trials from January 1, 2002, to September 30, 2013. Study Selection Studies of TAVR that reported the New York Heart Association (NYHA) class, Short-Form (SF)-12/36 physical and mental component summary (points), or other measures of functional status. Data Extraction Two reviewers independently extracted the mean change (follow-up – baseline) in primary outcomes. Due to substantial heterogeneity, data were not pooled; the range (minimum, maximum) of mean change was summarized. Data Synthesis We identified 60 observational studies (56 pre-post comparison and 4 head-to-head comparative studies) and 2 randomized controlled trials (11,205 patients). Most studies showed a clinically important decrease in NYHA class at 6–11 months (range: −0.8, −2.1), 12–23 months (−0.8, −2.1), 24–35 months (−1.2, −2.6), and ≥36 months (−1.2, −1.6). The improvement in SF-12/36 physical component score was clinically important over 12 months (4.9, 26.9), while the change in mental component score was smaller (1.0, 8.9). Clinically important improvements were observed in other disease-specific measures and 6-minute walk test, but less consistently seen in general health measures. Limitations Comparative evidence is limited by few head-to-head studies of functional outcomes. Survivor bias may have overestimated the benefits. Conclusions TAVR provides clinically important benefits in physical function and disease-specific measures of quality of life, but modest benefits in psychological and general health measures. More comparative studies on functional status and quality of life are needed for informed treatment decision-making.

show abstract

“…Cardiovascular disease is a major health problem causing substantial illness and death worldwide (Goncalves et al , 2013, Padala et al , 2011. Valvular heart disease is one of the most common forms of cardiovascular disease and is expected to triple by 2050 (Takkenberg et al , 2008).…”

Section: Introductionmentioning

confidence: 99%

Bioprinting a cardiac valve

Jana

Lerman

2015

Biotechnology Advances

141

View full text Add to dashboard Cite

Quality of life improvement at midterm follow-up after transcatheter aortic valve implantation

Cited by 36 publications

References 27 publications

A simple echo-Doppler sign to assess improved myocardial performance after transcatheter aortic valve implantation

A simple echo-Doppler sign to assess improved myocardial performance after transcatheter aortic valve implantation

Functional Status and Quality of Life After Transcatheter Aortic Valve Replacement

Bioprinting a cardiac valve

Contact Info

Product

Resources

About